Now showing items 1-2 of 2
Empagliflozin improves cardiorespiratory fitness in type 2 diabetes: Translational implications
(NRC Research Press, 2018-11)
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have been shown to prevent heart failure and reduce cardiovascular death in patients with type 2 diabetes (T2DM) and cardiovascular disease (CVD). Whether or not SGLT2 ...
Precision in Promoting Physical Activity and Exercise with the Overarching Goal of Moving More
(WB Saunders, 2019-01)
Physical inactivity is strongly associated with an unfavorable health profile, increasing an individual’s risk for developing cardiovascular disease. Initiating a regular exercise routine contributes to improvements in ...